However, the exact mechanisms by which DHM prevents and treats NAFLD remain unclear, including whether it modulates the intestinal flora and subsequently regulates the TLR4/NF-κB signaling pathway to impact NAFLD [22, -24]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.